What is the latest in the management of coronary artery disease in TAVI candidates?
Ole De Backer and Daniel Blackman discuss the management of coronary artery disease in TAVI candidates at #europcr 2026, focusing on whether PCI should be performed before valve implantation or can be safely deferred.
They review PROTAVI, which supports a more selective strategy with PCI only when clinically indicated, suggesting less bleeding without clear harm from deferral. They contrast this with NOTION-3, which suggests a potential benefit of more systematic revascularisation before TAVI, but with important differences in design and endpoint definitions, particularly the inclusion of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.